Researchers at Karolinska Institutet have identified a new vaccine candidate against pneumococci, bacteria that can cause pneumonia, sepsis, and meningitis. The vaccine molecules comprise nano-sized membrane vesicles...
A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials. Professor James Paton, Director of the University of Adelaide’s Research...
A survey of serogroup 6 Streptococcus pneumoniae isolates from children in China has identified no antibiotic-resistant clones, leading the authors to speculate that the isolates may be under antibiotic selective...
Type 3 innate lymphoid cells (ILC3) in the lung mucosa are activated early in the course of infection with Streptococcus pneumoniae and are a major source of interleukin (IL)-22 production, research reveals. The...
The spread of virulent, antibiotic-resistant strains of Streptococcus pneumoniae may be controllable through the use of competence-stimulating peptide (CSP) analogues, US researchers believe. Using a mouse model of S...